Marathon Nextgen Realty H1 Revenue Up, But Net Profit Declines

REAL-ESTATE
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Marathon Nextgen Realty H1 Revenue Up, But Net Profit Declines

Marathon Nextgen Realty reported a rise in half-yearly revenue to Rs 326.45 crore, though consolidated net profit dipped to Rs 97.62 crore from Rs 128.11 crore last year. The board also deferred new project investment plans and inducted Devendra Shrimanker into the audit committee.

Marathon Nextgen Realty Reports H1 Results

Consolidated Revenue: Rs 326.45 crore | Consolidated Net Profit: Rs 97.62 crore

Reader Takeaway: Revenue growth signals strong operational activity, but profit contraction and deferred investment plans warrant cautious investor observation.

What just happened

Marathon Nextgen Realty announced its unaudited financial results for the quarter and half-year ended September 30, 2026. While the company recorded higher consolidated revenue from operations at Rs 326.45 crore compared to Rs 257.67 crore in the prior-year period, consolidated net profit fell to Rs 97.62 crore from Rs 128.11 crore. The board also inducted Mr. Devendra Shrimanker as a member of the Audit Committee and approved the allotment of 24,005 equity shares under its ESOP 2020 scheme.

Why this matters

The divergence between rising revenues and falling profits highlights changing margins or operational costs that shareholders should monitor. Furthermore, the board’s decision to defer new or additional investments in projects and Special Purpose Vehicles (SPVs) signals a potential pause or reconsideration in the company’s capital deployment strategy.

Corporate Updates

As of September 30, 2026, the company has utilized Rs 695.39 crore of its total QIP proceeds of Rs 899.99 crore. The remaining funds are held in liquid assets, including mutual funds, debentures, and bonds. Additionally, the company is progressing with its amalgamation scheme, having filed the second motion on September 24, 2026.

Risks to watch

Investors should keep a close eye on the company's future disclosures regarding the deferred investment agenda. The lack of clarity on the timeline for these capital allocations may impact near-term growth expectations. Additionally, the decline in bottom-line performance will be a key metric to track in subsequent quarters.

What to track next

Watch for upcoming board meeting disclosures regarding the deferred investment plans and any updates on the ongoing amalgamation process.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.